Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0080-2027

Glypto Device, Glypto Cryo Machine; Recall

Glypto Device, Glypto Cryo Machine;

FDA recall Class II

Ongoing

FDA lists this Class II recall for Glypto Device, Glypto Cryo Machine;. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0080-2027
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Aug 24, 2026
FDA report date
Oct 14, 2026
Quantity in commerce
219
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Glypto Device, Glypto Cryo Machine;

The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.

Search FDA identifier text

Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.

This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.

FDA code information

All Glypto units distributed, placed, held, loaned, inventoried, or otherwise supplied by/through Limitless through the 08/11/2026 operational hold; 08/20/2026 preliminary field notice. Serial/account-specific consignee list attached or to be supplemented.

View the original FDA recall notice

Why was this product recalled?

Lack of 510(k) clearance.

What actions did Limitless Cryo Spa LLC take?

On August 24, 2026, Urgent Medical Device Recall letters were sent to customers. Actions to be taken: 1. Stop using every Glypto device immediately. 2. Unplug the device, clearly mark or tag it as QUARANTINED / DO NOT USE, and secure it in a location where it cannot be used pending removal from your facility or other writte n disposition instructions from Limitless. 3. Do not open, clean, service, repair, modify, move, ship, return, sell, transfer, loan, discard, or destroy any Glypto device or component unless Limitless provides written recall instructions. 4. Complete and return the attached Recall Response Form by the response due date above, even if you no longer have the device. 5. Read the serial number or other identifier from the device label/nameplate if present and provide it on the response form. If no label/nameplate is present or it cannot be read, state that on the form and attach clear device photos. 6. Identify the current location and status of each Glypto device and whether it is in your possession, in customer possession, in storage, loaned out, transferred, returned, or no longer available. 7. If you sold, transferred, loaned, placed, or otherwise provided a Glypto device to another person or entity, stop any further distribution and provide Limitless with the downstream recipient's name, telephone number, email, and address. 8. Preserve all Glypto-related records, including purchase, sales, service, repair, training, complaint, adverse-event, refund, text, email, Slack/direct-message, and downstream distribution records. 9. Report any complaint, device problem, injury, medical visit, service/repair issue, workaround, or other safety concern involving a Glypto device to Limitless.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology